Santa Fe Industries, Inc. v. Green
Headline: Court limits federal securities fraud rule, ruling it does not reach majority shareholder short‑form mergers without deception, making it harder for minority shareholders to bring federal fraud claims.
Holding: The Court held that the federal anti‑fraud securities rule (Section 10(b) and Rule 10b‑5) does not reach a Delaware short‑form merger that involves no deception or manipulation, so minority shareholders have no federal fraud claim.
- Limits federal securities fraud claims in non‑deceptive "going private" mergers.
- Preserves Delaware appraisal remedy as the primary path for minority shareholders.
- Reduces federal oversight of internal corporate merger disputes without deception.
Summary
Background
A large parent company that already owned most stock used Delaware’s short‑form merger law to buy the remaining shares of a smaller company and offered minority shareholders $150 per share. The parent included appraisals showing the company’s physical assets and a bank’s stock valuation of $125 per share. Minority shareholders said the merger froze them out at an unfair price (they claimed at least $772 per share) and sued in federal court under the federal anti‑fraud securities rule instead of pursuing Delaware’s appraisal remedy.
Reasoning
The Court asked whether the federal anti‑fraud rule (Section 10(b) and Rule 10b‑5) reaches a merger that involves no deception or market manipulation. Relying on the statute’s language and recent precedent, the Court said Rule 10b‑5 targets manipulative or deceptive practices, not ordinary breaches of corporate duty where full disclosure was made. Because the information statement disclosed the appraisals and shareholders could seek a Delaware appraisal, the Court found no deceptive or manipulative conduct and reversed the appeals court.
Real world impact
The ruling limits federal securities fraud suits in "going private" or short‑form mergers that involve no misrepresentation or market manipulation. Minority shareholders must generally rely on state remedies like Delaware’s appraisal process rather than federal Rule 10b‑5 claims. The decision keeps internal corporate fairness disputes largely governed by state law.
Dissents or concurrances
One Justice would have affirmed; two concurring Justices declined to join a broader federal‑preemption discussion and emphasized that full disclosure and the appraisal remedy matter here.
Opinions in this case:
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?